ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announced today that Zoran Antonijevic is the Vice President, Statistical...
BELFAST, Northern Ireland--(BUSINESS WIRE)--Re-Vana Therapeutics, a specialty ocular therapeutic and drug delivery company that specializes in the development of photo-crosslinked drug delivery technologies for...
ZAVENTEM, Belgium--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the European Commission has granted the marketing authorization for Solensia® (frunevetmab), a new feline osteoarthritis treatment...
TOKYO & MUNICH & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced Ken Takeshita, MD will be named the new...
UTRECHT, The Netherlands & PHILADELPHIA--(BUSINESS WIRE)--LAVA Therapeutics B.V., an early clinical-stage biotechnology company focused on applying its expertise in bispecific gamma-delta T cell engagers...
JERUSALEM--(BUSINESS WIRE)--NovellusDx (or the “Company”), a clinical-stage biotechnology company focused on precision oncology, today announced that it is establishing Fore Biotherapeutics U.S. as its...
